Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tjalf Ziemssen

Showing results (1-10 of 464) with videos related to

Pageof 47
Sort By:
Neurodegenerative Disease Management|November 28, 2015
Physician-patient communication skills: e-toolsTjalf Ziemssen
Neurology|November 7, 2022
Reader Response: NfL as Analogue of C-Reactive Protein in Neurologic Diseases: Instructions for UseTjalf Ziemssen
Advances in Experimental Medicine and Biology|February 24, 2004
Neuroprotection and glatiramer acetate: the possible role in the treatment of multiple sclerosisTjalf Ziemssen
Journal of Neurology|March 21, 2009
What can we learn from failed clinical trials in multiple sclerosis?Tjalf Ziemssen
Journal of the Neurological Sciences|February 10, 2009
Multiple sclerosis beyond EDSS: depression and fatigueTjalf Ziemssen
Neurodegenerative Disease Management|January 19, 2019
Tetrahydrocannabinol: cannabidiol oromucosal spray for treating symptoms of multiple sclerosis spasticity: newest evidenceTjalf Ziemssen
Journal of Neurology|October 29, 2005
Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosisTjalf Ziemssen
Journal of the Neurological Sciences|December 31, 2011
Symptom management in patients with multiple sclerosisTjalf Ziemssen
Current Pharmaceutical Design|May 23, 2012
Psychoneuroimmunology - psyche and autoimmunityTjalf Ziemssen
International Review of Neurobiology|May 29, 2007
Glatiramer acetate: mechanisms of action in multiple sclerosisTjalf Ziemssen, Wiebke Schrempf
Pageof 47

Showing results (1-10 of 464) with videos related to

Sort By:
Pageof 47
Neurodegenerative Disease Management|November 28, 2015
Physician-patient communication skills: e-toolsTjalf Ziemssen
Neurology|November 7, 2022
Reader Response: NfL as Analogue of C-Reactive Protein in Neurologic Diseases: Instructions for UseTjalf Ziemssen
Advances in Experimental Medicine and Biology|February 24, 2004
Neuroprotection and glatiramer acetate: the possible role in the treatment of multiple sclerosisTjalf Ziemssen
Journal of Neurology|March 21, 2009
What can we learn from failed clinical trials in multiple sclerosis?Tjalf Ziemssen
Journal of the Neurological Sciences|February 10, 2009
Multiple sclerosis beyond EDSS: depression and fatigueTjalf Ziemssen
Neurodegenerative Disease Management|January 19, 2019
Tetrahydrocannabinol: cannabidiol oromucosal spray for treating symptoms of multiple sclerosis spasticity: newest evidenceTjalf Ziemssen
Journal of Neurology|October 29, 2005
Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosisTjalf Ziemssen
Journal of the Neurological Sciences|December 31, 2011
Symptom management in patients with multiple sclerosisTjalf Ziemssen
Current Pharmaceutical Design|May 23, 2012
Psychoneuroimmunology - psyche and autoimmunityTjalf Ziemssen
International Review of Neurobiology|May 29, 2007
Glatiramer acetate: mechanisms of action in multiple sclerosisTjalf Ziemssen, Wiebke Schrempf
Pageof 47